U.S. animal experiments: No need to develop a booster vaccine for Omicron
- Fasting for 16 hours a day may increase the risk of cardiovascular death by 91%
- FDA Approves Groundbreaking Gene Therapy from UK’s Orchard Therapeutics
- Breakthrough in CAR-T therapy: Tumors almost completely disappear in just 5 days
- Adapalene can effectively activate senescence in prostate cancer cells and increase NK cell anti-tumor activity
- mRNA Therapy Unveils Hidden Cancer Cells: BioNTech’s IL-2 Breakthrough
- “Blood Test for Cancer”: Accuracy Up to 83% for Colorectal Cancer
U.S. animal experiments: No need to develop a booster vaccine for Omicron
- Long COVID Brain Fog: Blood-Brain Barrier Damage and Persistent Inflammation
- Japan: Over 10,000 Applications for Health Damage from COVID-19 Vaccines
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- ‘Elixir of Immortality’ Nicotinamide Riboside (NR) Virtually No Effect
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
U.S. animal experiments show that there is no need to develop a booster vaccine for Omicron.
U.S. researchers said today that monkey experiments showed that there was no significant difference in protection between the existing Moderna vaccine booster and the booster against the Omicron variant, suggesting that there may be no need to develop a booster specifically against Omicron.
Reuters reported: In this experiment, monkeys were first given two doses of Moderna’s COVID-19 (coronavirus disease 2019) vaccine. After 9 months, a third dose of traditional Moderna or a booster shot specifically for Omicron was administered.
The researchers then tested various aspects of the monkeys’ immune responses and exposed them to the virus. The study found that the two boosters produced “comparably and significantly increased neutralizing antibody responses” against all variants of high concern (VOC), including the Omicron variant.
Both Moderna and Pfizer/BioNTech have begun human clinical trials of the Omicron booster.
“This is very, very good news,” study co-author Daniel Douek, a vaccine researcher at the National Institutes of Allergy and Infectious Diseases (NIAID), said in a telephone interview. It becomes the Omicron-specific vaccine.”
Duke believes that both the original vaccine and the Omicron-specific vaccine have a “cross-reactive” effect and can recognize many different variants, so they can play this role.
Dr. John Moore, a professor at Weill Cornell Medical College who was not involved in the study, said the results were consistent with tests of the Beta variant of the Moderna booster. The results were similar.
“The monkey data is usually very predictive, but the human data has to be looked at,” he said.
U.S. animal experiments show that there is no need to develop a booster vaccine for Omicron.
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.